Relative value opportunity in property & casualty sector
admin | December 11, 2020
This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors.
Axis Capital Holdings Ltd. (AXS) offers attractive spread pick to property & casualty peers in the 5- to 10-year part of the curve. The AXS 29s are trading considerably wide of BBB/A peers in the 10-year part of the curve and appear to compensate investors for the risks commensurate with the issuer. While there is some near-term ratings risk of potential downgrades, that downside appears largely priced in, as AXS is trading well wide of mid-BBB rated peers in the property & casualty and reinsurance space.
Exhibit 1: AXS vs P&C/Reinsurance Comps
Source: Amherst Pierpont, Bloomberg/TRACE BVAL Indications
AXS 3.9% 7/15/29 @ +160-155 (cuff); G~172; ~2.49%; ~$110.55
AXS 4.0% 12/06/27 @ +135-130 (cuff); G~161; ~2.23%; ~$111.00
Issuer: AXIS Specialty Finance LLC (unconditionally guaranteed by AXS)
CUSIPs: 05463HAB7, 05464HAC4
Amounts outstanding: $300 million, $350 million
Ratings: Baa1/NEG, A-/NEG, BBB+/NEG
Operating Comps: AGCL, PRE, RE, RNR, XL, Y
AXS is a hybrid reinsurance/property & casualty operator, some of whose closest operating comps include Alleghany (Y: Baa1/BBB+), Arch Capital (ACGL: Baa1/A-/BBB+) and PartnerRe (PRE: Baa1/BBB/BBB). The company generates about 53% of premiums from insurance and the remaining 47% from reinsurance. AXS offers a wide product array across property and casualty lines, professional liability, workers’ compensation, and growing specialty lines such as marine/aviation.
Part of the initial rationale for the negative outlooks from the rating agencies included temporarily deficient capital following the acquisition of Novae Group Ltd for $460 million, which closed in late 2017. AXS has since resolved that issue, regaining capital adequacy at the AAA level, according to the agencies. Other concerns regard ongoing weakness in operational metrics, not just those related to COVID-19, which AXS should be able to resolve through continued improvements in pricing and better risk selection.
AXS took a conservative approach to COVID-related exposures, booking a $235 million charge in the first quarter of 2020. They have not made any additional adjustments or disclosures in the two quarters since then. AXS experienced an earnings setback in the third quarter of 2020 due to elevated cat losses on numerous global and weather-related events in the quarter.
AXS has a solid liquidity profile. The company has just over $1 billion on the balance sheet following the losses booked year-to-date. Their first senior debt maturity is not until 2027, however they have $250 million in loans due in 2021 and $500 million in loans due in 2023. AXS could opt to bring a senior debt deal to meet those near-term obligations, which could benefit secondary bonds by lending some price discovery in the issuer.
This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.
Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.
In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.
The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.
In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.
Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.